Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03661255 · ClinicalTrials.gov registry record · NA

Promoting Community Conversations About Research to End Native Youth Suicide in Rural Alaska

A NA study of Suicide, sponsored by University of Michigan.

Active
Registry status
NA
Development phase
1,491
Enrollment target
1
Study location

NCT03661255: Active NA study of Suicide, sponsored by University of Michigan.

NCT03661255 is a NA study of Suicide that is active but no longer recruiting, run by University of Michigan. The registered enrollment target is 1,491 participants, below the 6,974-participant average among 92 other Suicide trials with a reported enrollment target (79% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03661255, a NA study of Suicide, is active but no longer recruiting, sponsored by University of Michigan.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
1,491 participants
Enrollment target
1
Study location

Study Summary

This intervention study measures the outcomes of the PC CARES (Promoting Community Conversations about Research to End Suicide) project implemented in remote rural Alaskan villages. Researchers worked with local service providers and other partners to recruit facilitators who were trained to implement the 5-session PC CARES curriculum. The study will compare pre-post data from intervention participants to non-participants, and will analyze social networks related to suicide prevention behavior in each village.

Primary Outcome

The Wellness Self-Efficacy scale includes two items: 1. I know how I can make positive changes for school wellness 2. There are things I can do to promote wellness here Items were measured on a 7-point Likert scale with response options ranging from Strongly Disagree (1) to Strongly Agree (7) with a neutral midpoint. Responses to the two items are averaged to calculate a composite Wellness Self-Efficacy score ranging from 1 to 7. The reported outcome measure is the mean (standard deviation) o

Conditions Studied

Interventions

  • BEHAVIORAL PC CARES

Study Locations (1)

Michigan

  • University of Michigan - Ann Arbor

Trial Details

FieldValue
Enrollment Target 1,491 participants
Start Date 2019-09-12
Est. Completion 2025-12-15
Phase NA
University of Michigan

1,327 total trials

What the registry record for NCT03661255 still lists

NCT03661255 is an interventional study that assigns participants to a tested intervention. Its 1,491 participants enrollment target places it among the larger protocols in the corpus, below the 6,974-participant average among 92 other Suicide trials with a reported enrollment target (79% lower).

The record links to 1 condition, with Suicide appearing as the primary indexed condition, and to 1 intervention - of which PC CARES is the first listed.

NCT03661255 reports a single indexed study location in Michigan.

Frequently Asked Questions

What is clinical trial NCT03661255 about?

NCT03661255 is a clinical study titled "Promoting Community Conversations About Research to End Native Youth Suicide in Rural Alaska". This intervention study measures the outcomes of the PC CARES (Promoting Community Conversations about Research to End Suicide) project implemented in remote rural Alaskan villages. Researchers worked with local service providers and other partners to recruit facilitators who were trained to impleme...

What is the current status of trial NCT03661255?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 1,491 participants. The study started on 2019-09-12. Estimated completion is 2025-12-15.

What conditions does trial NCT03661255 study?

This clinical trial studies the following conditions: Suicide.

What interventions are being tested in trial NCT03661255?

The interventions under investigation include: PC CARES (BEHAVIORAL).

Who is sponsoring clinical trial NCT03661255?

This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03661255 being conducted?

This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Suicide

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT03661255's enrollment target sits among peer trials

1,491 10th of 92 higher than 83 of 92 other Suicide trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Suicide trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00178724 · 1,500 participants

    Spinal Cord Injury Registry - North American Clinical Trials Network

  • NCT00951366 · 1,500 participants

    Preterm Lung Patient Registry

  • NCT01050504 · 1,500 participants

    Collecting and Studying Blood and Tissue Samples From Patients With Locally Recurrent or Metastatic Prostate or Bladder/Urothelial Cancer

  • NCT02071134 · 1,500 participants

    Registry of Deep Brain Stimulation With the VERCISE™ System: Vercise DBS Registry

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03661255, the US trial registry maintained by the National Library of Medicine. NCT03661255 (large enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.